000 01363 a2200337 4500
005 20250517160914.0
008 ####s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2017.00625
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMordoh, José
245 0 0 _aPhase II Study of Adjuvant Immunotherapy with the CSF-470 Vaccine Plus Bacillus Calmette-Guerin Plus Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor vs Medium-Dose Interferon Alpha 2B in Stages IIB, IIC, and III Cutaneous Melanoma Patients: A Single Institution, Randomized Study.
_h[electronic resource]
260 _bFrontiers in immunology
_c2017
300 _a625 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aPampena, María Betina
700 1 _aAris, Mariana
700 1 _aBlanco, Paula Alejandra
700 1 _aLombardo, Mónica
700 1 _avon Euw, Erika María
700 1 _aMac Keon, Soledad
700 1 _aYépez Crow, Michelle
700 1 _aBravo, Alicia Inés
700 1 _aO'Connor, Juan Manuel
700 1 _aOrlando, Ana Gabriela
700 1 _aRamello, Franco
700 1 _aLevy, Estrella Mariel
700 1 _aBarrio, María Marcela
773 0 _tFrontiers in immunology
_gvol. 8
_gp. 625
856 4 0 _uhttps://doi.org/10.3389/fimmu.2017.00625
_zAvailable from publisher's website
999 _c27283124
_d27283124